| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.729 | 0.02 | 0.729 | Caspase 9 stimulant | |||
| 0.605 | 0.003 | 0.605 | Porphobilinogen synthase inhibitor | 0.191 0.013 CID_10683971 | ||
| 0.602 | 0.002 | 0.697 | Triose-phosphate isomerase inhibitor | 0.697 0.001 CID_10683971 | CID_10683971 | |
| 0.578 | 0.008 | 0.796 | Superoxide dismutase inhibitor | 0.796 0.003 CID_10683971 | CID_10683971 | |
| 0.553 | 0.012 | 0.553 | Calcium channel L-type activator | |||
| 0.488 | 0.015 | 0.488 | DNA damaging | 0.2 0.116 CID_10683971 | ||
| 0.538 | 0.069 | 0.538 | Alpha-glucosidase inhibitor | 0.275 0.173 CID_10683971 | ||
| 0.466 | 0.003 | 0.466 | UDP-glucose 4-epimerase inhibitor | 0.179 0.021 CID_10683971 | ||
| 0.455 | 0.003 | 0.455 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 CID_10683971 | ||
| 0.443 | 0.003 | 0.443 | Histidine decarboxylase inhibitor | |||
| 0.425 | 0.021 | 0.425 | Interleukin 2 agonist | |||
| 0.399 | 0.009 | 0.399 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.396 | 0.009 | 0.396 | Amylase inhibitor | |||
| 0.39 | 0.003 | 0.39 | Mannose-6-phosphate isomerase inhibitor | 0.167 0.051 CID_10683971 | ||
| 0.407 | 0.022 | 0.407 | Calcium channel activator | 0.279 0.114 CID_10683971 | ||
| 0.428 | 0.047 | 0.428 | Vasodilator, peripheral | |||
| 0.384 | 0.004 | 0.384 | Alcohol oxidase inhibitor | |||
| 0.384 | 0.008 | 0.384 | Alkylator | 0.26 0.015 CID_10683971 | ||
| 0.374 | 0.004 | 0.374 | Nitric-oxide synthase stimulant | 0.187 0.112 CID_10683971 | ||
| 0.398 | 0.063 | 0.398 | Calpain 2 inhibitor | |||
| 0.381 | 0.054 | 0.381 | Cholesterol antagonist | 0.324 0.077 CID_10683971 | ||
| 0.329 | 0.005 | 0.329 | Adenylate kinase inhibitor | 0.229 0.012 CID_10683971 | ||
| 0.37 | 0.046 | 0.37 | Vasodilator, coronary | |||
| 0.339 | 0.022 | 0.68 | Dual specificity phosphatase 3 inhibitor | 0.68 0.004 CID_10683971 | CID_10683971 | |
| 0.319 | 0.008 | 0.319 | Succinate dehydrogenase inhibitor | 0.226 0.032 CID_10683971 | ||
| 0.357 | 0.048 | 0.357 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.413 | 0.107 | 0.413 | Apoptosis agonist | 0.28 0.187 CID_10683971 | ||
| 0.311 | 0.02 | 0.311 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.323 | 0.038 | 0.323 | Interleukin agonist | |||
| 0.374 | 0.089 | 0.471 | Histamine release inhibitor | 0.471 0.04 CID_10683971 | CID_10683971 | |
| 0.374 | 0.089 | 0.519 | Antibacterial | 0.519 0.035 CID_10683971 | CID_10683971 | |
| 0.286 | 0.003 | 0.286 | Biliverdin reductase inhibitor | 0.089 0.022 CID_10683971 | ||
| 0.293 | 0.012 | 0.293 | Aldehyde dehydrogenase inhibitor | |||
| 0.298 | 0.027 | 0.298 | DNA methyltransferase I inhibitor | |||
| 0.311 | 0.058 | 0.311 | Aryl hydrocarbon receptor agonist | |||
| 0.274 | 0.021 | 0.274 | Protein kinase stimulant | |||
| 0.296 | 0.045 | 0.296 | DNA synthesis inhibitor | |||
| 0.338 | 0.087 | 0.338 | Prostaglandin dehydrogenase inhibitor | |||
| 0.319 | 0.07 | 0.319 | 12-Lipoxygenase inhibitor | |||
| 0.253 | 0.005 | 0.253 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.253 | 0.006 | 0.253 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.089 0.044 CID_10683971 | ||
| 0.271 | 0.024 | 0.271 | Cytidine deaminase inhibitor | |||
| 0.275 | 0.033 | 0.664 | Dual specificity phosphatase inhibitor | 0.664 0.004 CID_10683971 | CID_10683971 | |
| 0.244 | 0.008 | 0.244 | Phosphofructokinase-1 inhibitor | 0.13 0.023 CID_10683971 | ||
| 0.246 | 0.01 | 0.246 | Carbonic anhydrase III inhibitor | 0.174 0.021 CID_10683971 | ||
| 0.272 | 0.037 | 0.272 | DNA methylase inhibitor | |||
| 0.239 | 0.008 | 0.239 | CF transmembrane conductance regulator agonist | |||
| 0.235 | 0.006 | 0.235 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 CID_10683971 | ||
| 0.357 | 0.143 | 0.357 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.258 | 0.045 | 0.278 | RNA-directed DNA polymerase inhibitor | 0.278 0.037 CID_10683971 | CID_10683971 | |
| 0.225 | 0.016 | 0.295 | Aminopeptidase B inhibitor | 0.295 0.009 CID_10683971 | CID_10683971 | |
| 0.211 | 0.009 | 0.211 | Creatine kinase inhibitor | 0.137 0.03 CID_10683971 | ||
| 0.265 | 0.063 | 0.265 | Gastrin inhibitor | |||
| 0.251 | 0.05 | 0.251 | Anesthetic general | |||
| 0.21 | 0.013 | 0.21 | Potassium channel (Ca-activated) activator | |||
| 0.202 | 0.004 | 0.202 | Thioredoxin reductase inhibitor | 0.101 0.027 CID_10683971 | ||
| 0.221 | 0.025 | 0.221 | Hexokinase inhibitor | |||
| 0.204 | 0.008 | 0.204 | Thioredoxin inhibitor | 0.11 0.039 CID_10683971 | ||
| 0.212 | 0.019 | 0.212 | Cathepsin H inhibitor | 0.156 0.042 CID_10683971 | ||
| 0.291 | 0.099 | 0.291 | Transcription factor NF kappa B inhibitor | |||
| 0.253 | 0.065 | 0.253 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.227 | 0.039 | 0.227 | Histone acetyltransferase inhibitor | |||
| 0.212 | 0.026 | 0.282 | Cell wall synthesis inhibitor | 0.282 0.011 CID_10683971 | CID_10683971 | |
| 0.323 | 0.14 | 0.323 | 5 Hydroxytryptamine release inhibitor | |||
| 0.201 | 0.019 | 0.201 | Interleukin 1b antagonist | |||
| 0.249 | 0.069 | 0.249 | Vasodilator | |||
| 0.256 | 0.079 | 0.256 | Transcription factor STAT3 inhibitor | |||
| 0.206 | 0.033 | 0.206 | NADPH oxidase inhibitor | |||
| 0.181 | 0.009 | 0.181 | Argininosuccinate synthase inhibitor | |||
| 0.24 | 0.073 | 0.24 | Free radical scavenger | |||
| 0.199 | 0.033 | 0.199 | Interleukin 1 antagonist | |||
| 0.177 | 0.012 | 0.177 | Glutamate dehydrogenase inhibitor | 0.1 0.031 CID_10683971 | ||
| 0.195 | 0.032 | 0.195 | Toll-Like receptor antagonist | |||
| 0.174 | 0.012 | 0.174 | DOPA decarboxylase inhibitor | |||
| 0.212 | 0.05 | 0.212 | Mcl-1 antagonist | |||
| 0.249 | 0.088 | 0.249 | Transcription factor STAT inhibitor | |||
| 0.254 | 0.094 | 0.359 | Immunostimulant | 0.359 0.062 CID_10683971 | CID_10683971 | |
| 0.194 | 0.035 | 0.194 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.171 | 0.012 | 0.171 | Toll-Like receptor 4 antagonist | |||
| 0.171 | 0.015 | 0.171 | Urease inhibitor | 0.101 0.066 CID_10683971 | ||
| 0.165 | 0.009 | 0.165 | Glutathione S-transferase inhibitor | |||
| 0.183 | 0.028 | 0.183 | Interleukin 4 antagonist | |||
| 0.163 | 0.009 | 0.163 | Ornithine carbamoyltransferase inhibitor | 0.087 0.019 CID_10683971 | ||
| 0.171 | 0.018 | 0.182 | Carbonic anhydrase XIII inhibitor | 0.182 0.016 CID_10683971 | CID_10683971 | |
| 0.182 | 0.031 | 0.182 | DNA intercalator | |||
| 0.186 | 0.037 | 0.186 | Monophenol monooxygenase inhibitor | 0.142 0.05 CID_10683971 | ||
| 0.195 | 0.047 | 0.28 | Phospholipase C inhibitor | 0.28 0.02 CID_10683971 | CID_10683971 | |
| 0.163 | 0.015 | 0.163 | NADH dehydrogenase inhibitor | 0.092 0.054 CID_10683971 | ||
| 0.229 | 0.086 | 0.229 | Calpain inhibitor | |||
| 0.183 | 0.04 | 0.264 | Alkaline phosphatase inhibitor | 0.264 0.017 CID_10683971 | CID_10683971 | |
| 0.146 | 0.004 | 0.146 | Catechol O-methyltransferase inhibitor | 0.05 0.009 CID_10683971 | ||
| 0.301 | 0.161 | 0.301 | DNA directed DNA polymerase inhibitor | |||
| 0.193 | 0.056 | 0.193 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.156 | 0.021 | 0.156 | Androgen antagonist | |||
| 0.154 | 0.02 | 0.154 | Carbonic anhydrase VI inhibitor | 0.095 0.043 CID_10683971 | ||
| 0.16 | 0.026 | 0.16 | Photosensitizer | |||
| 0.233 | 0.1 | 0.233 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.14 | 0.008 | 0.14 | Purinergic P2X1 antagonist | 0.093 0.019 CID_10683971 | ||
| 0.162 | 0.03 | 0.162 | GABA C receptor agonist | |||
| 0.14 | 0.009 | 0.231 | NMDA receptor agonist | 0.231 0.004 CID_10683971 | CID_10683971 | |
| 0.153 | 0.023 | 0.154 | Breast cancer-resistant protein inhibitor | 0.154 0.022 CID_10683971 | CID_10683971 | |
| 0.254 | 0.124 | 0.254 | Apoptosis antagonist | |||
| 0.16 | 0.031 | 0.16 | Xanthine oxidase inhibitor | |||
| 0.162 | 0.033 | 0.162 | Ferrochelatase inhibitor | |||
| 0.142 | 0.013 | 0.142 | Interleukin 5 antagonist | |||
| 0.151 | 0.024 | 0.151 | Beta glucuronidase inhibitor | |||
| 0.129 | 0.002 | 0.129 | Glutamate (mGluR8) agonist | 0.05 0.012 CID_10683971 | ||
| 0.142 | 0.016 | 0.176 | Carbonic anhydrase V inhibitor | 0.176 0.01 CID_10683971 | CID_10683971 | |
| 0.129 | 0.006 | 0.129 | NMDA receptor glycine site agonist | 0.064 0.042 CID_10683971 | ||
| 0.222 | 0.1 | 0.222 | Antioxidant | 0.164 0.149 CID_10683971 | ||
| 0.241 | 0.12 | 0.241 | Caspase 3 stimulant | |||
| 0.198 | 0.079 | 0.198 | Neurotrophic factor enhancer | |||
| 0.135 | 0.016 | 0.135 | Glutamate decarboxylase inhibitor | 0.073 0.051 CID_10683971 | ||
| 0.131 | 0.014 | 0.131 | Potassium channel large-conductance Ca-activated activator | |||
| 0.207 | 0.09 | 0.207 | Peptidyltransferase inhibitor | |||
| 0.153 | 0.036 | 0.153 | Ca2+-transporting ATPase inhibitor | |||
| 0.126 | 0.011 | 0.126 | D-Ala-D-Ala ligase inhibitor | |||
| 0.124 | 0.009 | 0.124 | Androgen agonist | 0.094 0.017 CID_10683971 | ||
| 0.14 | 0.026 | 0.14 | Calcium antagonist | |||
| 0.146 | 0.032 | 0.146 | Carbonic anhydrase XV inhibitor | |||
| 0.147 | 0.034 | 0.147 | DNA repair enzyme inhibitor | |||
| 0.118 | 0.005 | 0.118 | Secretase gamma inhibitor | |||
| 0.16 | 0.047 | 0.16 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.178 | 0.066 | 0.178 | Peroxidase inhibitor | |||
| 0.171 | 0.061 | 0.171 | Neurotensin receptor agonist | |||
| 0.125 | 0.016 | 0.131 | Carbonic anhydrase VA inhibitor | 0.131 0.015 CID_10683971 | CID_10683971 | |
| 0.186 | 0.078 | 0.186 | Growth factor agonist | |||
| 0.119 | 0.01 | 0.119 | Phosphorylase inhibitor | 0.07 0.02 CID_10683971 | ||
| 0.149 | 0.042 | 0.149 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.116 | 0.011 | 0.116 | Bcl2 antagonist | 0.08 0.032 CID_10683971 | ||
| 0.146 | 0.042 | 0.146 | Vanilloid 1 agonist | |||
| 0.109 | 0.005 | 0.181 | Mannosidase inhibitor | 0.181 0.003 CID_10683971 | CID_10683971 | |
| 0.243 | 0.139 | 0.243 | Thioredoxin glutathione reductase inhibitor | |||
| 0.274 | 0.171 | 0.274 | Transcription factor inhibitor | |||
| 0.108 | 0.005 | 0.174 | Alpha-mannosidase inhibitor | 0.174 0.004 CID_10683971 | CID_10683971 | |
| 0.119 | 0.016 | 0.119 | GABA aminotransferase inhibitor | |||
| 0.111 | 0.009 | 0.111 | Glutamate (mGluR group III) agonist | |||
| 0.119 | 0.017 | 0.119 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.131 | 0.03 | 0.131 | Anabolic | 0.128 0.032 CID_10683971 | ||
| 0.104 | 0.004 | 0.104 | Thymidylate synthase inhibitor | |||
| 0.123 | 0.024 | 0.123 | Transcription factor NF kappa B stimulant | |||
| 0.128 | 0.031 | 0.222 | Catalase inhibitor | 0.222 0.012 CID_10683971 | CID_10683971 | |
| 0.18 | 0.087 | 0.18 | Non-steroidal antiinflammatory agent | |||
| 0.104 | 0.014 | 0.104 | GABA B receptor agonist | 0.071 0.065 CID_10683971 | ||
| 0.133 | 0.044 | 0.133 | TRPA1 agonist | 0.114 0.065 CID_10683971 | ||
| 0.246 | 0.158 | 0.246 | GABA C receptor rho-3 antagonist | |||
| 0.099 | 0.012 | 0.099 | AMPA receptor antagonist | |||
| 0.157 | 0.07 | 0.157 | Interferon gamma antagonist | |||
| 0.093 | 0.006 | 0.093 | Glutamate (mGluR4) antagonist | |||
| 0.133 | 0.048 | 0.133 | Topoisomerase I inhibitor | |||
| 0.12 | 0.035 | 0.12 | Alcohol dehydrogenase inhibitor | |||
| 0.117 | 0.034 | 0.117 | Potassium channel activator | |||
| 0.085 | 0.004 | 0.215 | NMDA 2D receptor antagonist | 0.215 0.003 CID_10683971 | CID_10683971 | |
| 0.159 | 0.078 | 0.159 | Heat shock protein 90 alpha antagonist | |||
| 0.086 | 0.006 | 0.086 | Ryanodine receptor antagonist | |||
| 0.145 | 0.066 | 0.151 | Cytokine production inhibitor | 0.151 0.061 CID_10683971 | CID_10683971 | |
| 0.097 | 0.018 | 0.097 | Maillard reaction inhibitor | |||
| 0.114 | 0.036 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.092 | 0.016 | 0.092 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.096 | 0.021 | 0.096 | Carbonic anhydrase XII inhibitor | 0.062 0.032 CID_10683971 | ||
| 0.152 | 0.078 | 0.152 | Melanin inhibitor | |||
| 0.087 | 0.013 | 0.087 | MDM2 inhibitor | |||
| 0.088 | 0.014 | 0.088 | Carbonic anhydrase XIV inhibitor | |||
| 0.121 | 0.048 | 0.121 | AMP-activated protein kinase stimulant | |||
| 0.087 | 0.016 | 0.087 | Nitric oxide donor | |||
| 0.1 | 0.029 | 0.1 | Interferon agonist | |||
| 0.089 | 0.019 | 0.124 | Carbonic anhydrase VB inhibitor | 0.124 0.012 CID_10683971 | CID_10683971 | |
| 0.123 | 0.055 | 0.123 | Transcription factor STAT6 inhibitor | |||
| 0.2 | 0.133 | 0.2 | Streptokinase A inhibitor | |||
| 0.12 | 0.053 | 0.12 | Chelator | |||
| 0.087 | 0.021 | 0.087 | NMDA 2C receptor antagonist | 0.081 0.025 CID_10683971 | ||
| 0.086 | 0.019 | 0.086 | Interferon inducer | 0.063 0.046 CID_10683971 | ||
| 0.114 | 0.048 | 0.114 | Bronchodilator | |||
| 0.127 | 0.062 | 0.127 | Anesthetic local | |||
| 0.076 | 0.011 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.038 CID_10683971 | ||
| 0.079 | 0.014 | 0.079 | NMDA receptor subunit 3B antagonist | |||
| 0.07 | 0.007 | 0.07 | Glutamate (mGluR4) agonist | |||
| 0.092 | 0.03 | 0.181 | Carbonic anhydrase inhibitor | 0.181 0.012 CID_10683971 | CID_10683971 | |
| 0.087 | 0.025 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.064 CID_10683971 | ||
| 0.073 | 0.011 | 0.073 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.04 CID_10683971 | ||
| 0.141 | 0.079 | 0.141 | Adenylate cyclase stimulant | |||
| 0.066 | 0.005 | 0.066 | Uridine phosphorylase inhibitor | |||
| 0.075 | 0.014 | 0.075 | Dihydroorotate oxidase inhibitor | |||
| 0.196 | 0.135 | 0.196 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.085 | 0.025 | 0.089 | Carbonic anhydrase IX inhibitor | 0.089 0.023 CID_10683971 | CID_10683971 | |
| 0.072 | 0.012 | 0.072 | Kainate receptor antagonist | |||
| 0.175 | 0.116 | 0.175 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.069 | 0.01 | 0.069 | AICAR transformylase inhibitor | 0.053 0.02 CID_10683971 | ||
| 0.19 | 0.13 | 0.19 | 5 Hydroxytryptamine release stimulant | |||
| 0.138 | 0.079 | 0.138 | Pregnane X receptor agonist | |||
| 0.082 | 0.024 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.148 | 0.091 | 0.148 | Arachidonic acid antagonist | |||
| 0.084 | 0.027 | 0.084 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.095 | 0.037 | 0.129 | Glycine receptor antagonist | 0.129 0.014 CID_10683971 | CID_10683971 | |
| 0.131 | 0.076 | 0.131 | Toll-Like receptor 9 antagonist | |||
| 0.065 | 0.011 | 0.065 | Glutamate (mGluR group III) antagonist | |||
| 0.101 | 0.046 | 0.184 | NMDA receptor antagonist | 0.184 0.017 CID_10683971 | CID_10683971 | |
| 0.096 | 0.042 | 0.096 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.197 | 0.143 | 0.197 | Lipoxygenase inhibitor | |||
| 0.085 | 0.032 | 0.085 | Vanilloid 4 agonist | |||
| 0.059 | 0.006 | 0.059 | Heme oxygenase inhibitor | |||
| 0.113 | 0.06 | 0.123 | Acetylcholine release stimulant | 0.123 0.044 CID_10683971 | CID_10683971 | |
| 0.061 | 0.009 | 0.061 | Nerve growth factor antagonist | |||
| 0.116 | 0.065 | 0.116 | Caspase 3 inhibitor | |||
| 0.061 | 0.011 | 0.061 | Kainate receptor 2 antagonist | |||
| 0.171 | 0.122 | 0.171 | Antiamyloidogenic | |||
| 0.063 | 0.013 | 0.063 | Collagenase inhibitor | 0.052 0.029 CID_10683971 | ||
| 0.071 | 0.021 | 0.071 | Prolactin release inhibitor | |||
| 0.064 | 0.015 | 0.064 | Potassium channel (Inward rectifier) activator | 0.046 0.044 CID_10683971 | ||
| 0.181 | 0.132 | 0.181 | Hypoglycemic | |||
| 0.118 | 0.069 | 0.118 | Topoisomerase II inhibitor | |||
| 0.075 | 0.027 | 0.075 | Xanthine dehydrogenase inhibitor | |||
| 0.136 | 0.089 | 0.136 | NOS3 expression enhancer | |||
| 0.089 | 0.042 | 0.101 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 CID_10683971 | CID_10683971 | |
| 0.061 | 0.015 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.045 0.042 CID_10683971 | ||
| 0.07 | 0.025 | 0.07 | Botulinum neurotoxin type A inhibitor | |||
| 0.1 | 0.054 | 0.1 | Interleukin 12 antagonist | |||
| 0.055 | 0.01 | 0.055 | Kainate receptor agonist | |||
| 0.066 | 0.021 | 0.066 | Aconitate hydratase inhibitor | |||
| 0.103 | 0.058 | 0.103 | MAO B inhibitor | |||
| 0.06 | 0.017 | 0.06 | NMDA receptor subunit 3A antagonist | |||
| 0.136 | 0.093 | 0.136 | MAP kinase 3 inhibitor | |||
| 0.154 | 0.112 | 0.154 | Pyruvate kinase inhibitor | |||
| 0.074 | 0.031 | 0.074 | Aromatase inhibitor | |||
| 0.097 | 0.055 | 0.117 | Bile acid receptor antagonist | 0.117 0.023 CID_10683971 | CID_10683971 | |
| 0.069 | 0.027 | 0.069 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.061 | 0.02 | 0.061 | CD45 antagonist | |||
| 0.069 | 0.029 | 0.069 | Calcium channel P-type blocker | |||
| 0.066 | 0.026 | 0.066 | NMDA 2A receptor antagonist | |||
| 0.064 | 0.025 | 0.064 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.108 | 0.068 | 0.108 | Cystathionine beta-synthase inhibitor | |||
| 0.052 | 0.013 | 0.069 | Phosphoglycerate kinase inhibitor | 0.069 0.01 CID_10683971 | CID_10683971 | |
| 0.116 | 0.077 | 0.116 | MAO inhibitor | |||
| 0.069 | 0.031 | 0.069 | Transcription factor RelA inhibitor | |||
| 0.132 | 0.093 | 0.132 | Thiol protease inhibitor | |||
| 0.165 | 0.127 | 0.165 | Aldehyde oxidase inhibitor | |||
| 0.057 | 0.019 | 0.057 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.074 | 0.036 | 0.074 | Neutrophil collagenase inhibitor | |||
| 0.078 | 0.04 | 0.078 | Prostaglandin-E synthase inhibitor | |||
| 0.049 | 0.011 | 0.049 | AMPA 1 receptor antagonist | |||
| 0.109 | 0.072 | 0.109 | CDK3/cyclin E inhibitor | |||
| 0.133 | 0.096 | 0.164 | Phospholipase A2 inhibitor | 0.164 0.063 CID_10683971 | CID_10683971 | |
| 0.044 | 0.008 | 0.044 | Kainate receptor 4 antagonist | |||
| 0.046 | 0.01 | 0.046 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.05 | 0.015 | 0.05 | AMPA 4 receptor antagonist | |||
| 0.055 | 0.019 | 0.055 | CDK7/cyclin H inhibitor | |||
| 0.064 | 0.03 | 0.064 | Bcl-xL inhibitor | |||
| 0.235 | 0.202 | 0.235 | DNA polymerase beta inhibitor | |||
| 0.043 | 0.01 | 0.043 | Cyclophilin A inhibitor | |||
| 0.083 | 0.051 | 0.083 | Topoisomerase II alpha inhibitor | |||
| 0.134 | 0.102 | 0.134 | Heat shock protein 70 antagonist | |||
| 0.038 | 0.006 | 0.038 | Estrogen-related receptor gamma antagonist | |||
| 0.049 | 0.018 | 0.049 | Dihydropteroate synthase inhibitor | |||
| 0.039 | 0.009 | 0.039 | NMDA receptor glycine site antagonist | |||
| 0.046 | 0.015 | 0.046 | Fumarate hydratase inhibitor | |||
| 0.069 | 0.039 | 0.146 | HIV-1 integrase (3'-Processing) inhibitor | 0.146 0.014 CID_10683971 | CID_10683971 | |
| 0.078 | 0.049 | 0.078 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | |||
| 0.047 | 0.018 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.032 | 0.003 | 0.032 | Glutamate (mGluR6) agonist | 0.012 0.009 CID_10683971 | ||
| 0.039 | 0.01 | 0.039 | Kynurenine 3 monooxygenase inhibitor | 0.029 0.016 CID_10683971 | ||
| 0.054 | 0.026 | 0.054 | Sodium/calcium exchanger inhibitor | |||
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | |||
| 0.063 | 0.036 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.064 | 0.036 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.056 | 0.029 | 0.056 | Glucose-6-phosphate translocase inhibitor | |||
| 0.055 | 0.028 | 0.055 | Antimetabolite | |||
| 0.15 | 0.123 | 0.737 | Angiogenesis stimulant | 0.737 0.004 CID_10683971 | CID_10683971 | |
| 0.04 | 0.014 | 0.04 | AMPA 3 receptor antagonist | |||
| 0.057 | 0.031 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.058 | 0.033 | 0.058 | Glucosylceramidase inhibitor | |||
| 0.069 | 0.045 | 0.069 | Exportin-1 inhibitor | |||
| 0.077 | 0.053 | 0.077 | Keratolytic | |||
| 0.074 | 0.049 | 0.076 | Cathepsin G inhibitor | 0.076 0.047 CID_10683971 | CID_10683971 | |
| 0.031 | 0.007 | 0.031 | Complement factor 1s inhibitor | |||
| 0.044 | 0.021 | 0.044 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.089 | 0.065 | 0.089 | Glutamate release inhibitor | |||
| 0.072 | 0.049 | 0.141 | NMDA 2 receptor antagonist | 0.141 0.018 CID_10683971 | CID_10683971 | |
| 0.031 | 0.009 | 0.031 | Kainate receptor 5 antagonist | |||
| 0.032 | 0.009 | 0.032 | Kainate receptor 1 antagonist | |||
| 0.061 | 0.041 | 0.151 | HIV-1 integrase (Strand Transfer) inhibitor | 0.151 0.013 CID_10683971 | CID_10683971 | |
| 0.032 | 0.011 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.199 | 0.178 | 0.353 | Antithrombotic | 0.353 0.063 CID_10683971 | CID_10683971 | |
| 0.059 | 0.04 | 0.059 | Glutamate (mGluR1) antagonist | |||
| 0.125 | 0.106 | 0.125 | Heat shock protein 90 antagonist | |||
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) blocker | |||
| 0.042 | 0.024 | 0.042 | GABA uptake inhibitor | |||
| 0.022 | 0.005 | 0.022 | Thromboxane A2 agonist | |||
| 0.021 | 0.004 | 0.021 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.043 | 0.027 | 0.043 | Angiotensin AT1 receptor antagonist | |||
| 0.097 | 0.082 | 0.097 | Mucolytic | |||
| 0.055 | 0.039 | 0.089 | Carbonic anhydrase I inhibitor | 0.089 0.021 CID_10683971 | CID_10683971 | |
| 0.065 | 0.05 | 0.065 | Glutamate (mGluR6) antagonist | |||
| 0.08 | 0.065 | 0.08 | Bcr-Abl kinase inhibitor | |||
| 0.042 | 0.027 | 0.042 | Thymidine kinase inhibitor | |||
| 0.07 | 0.055 | 0.07 | Metalloproteinase-9 inhibitor | |||
| 0.054 | 0.04 | 0.071 | Carbonic anhydrase II inhibitor | 0.071 0.029 CID_10683971 | CID_10683971 | |
| 0.048 | 0.035 | 0.048 | Plasminogen activator inhibitor antagonist | |||
| 0.026 | 0.012 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.022 | 0.009 | 0.022 | Progesterone receptor B antagonist | |||
| 0.095 | 0.082 | 0.095 | Factor V inhibitor | |||
| 0.042 | 0.03 | 0.054 | Guanylate cyclase inhibitor | 0.054 0.017 CID_10683971 | CID_10683971 | |
| 0.02 | 0.007 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Integrin alpha2beta1 antagonist | |||
| 0.096 | 0.085 | 0.2 | Multidrug resistance-associated protein 1 inhibitor | 0.2 0.01 CID_10683971 | CID_10683971 | |
| 0.02 | 0.009 | 0.02 | Kainate receptor 3 antagonist | |||
| 0.026 | 0.016 | 0.026 | Sodium/glucose cotransporter inhibitor | |||
| 0.025 | 0.015 | 0.048 | Glutamate (mGluR1) agonist | 0.048 0.005 CID_10683971 | CID_10683971 | |
| 0.033 | 0.024 | 0.033 | Free fatty acid receptor 1 antagonist | |||
| 0.014 | 0.005 | 0.014 | Thromboxane agonist | |||
| 0.095 | 0.086 | 0.095 | Protein kinase C gamma inhibitor | |||
| 0.032 | 0.023 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.016 | 0.008 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.049 | 0.041 | 0.049 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.029 | 0.022 | 0.029 | AMPA 2 receptor antagonist | |||
| 0.053 | 0.046 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.117 | 0.111 | 0.117 | Farnesoid X receptor antagonist | |||
| 0.025 | 0.019 | 0.025 | Acid ceramidase inhibitor | |||
| 0.065 | 0.059 | 0.065 | Calcium channel L-type blocker | |||
| 0.096 | 0.091 | 0.096 | DNA polymerase I inhibitor | |||
| 0.059 | 0.054 | 0.059 | Beta 2 adrenoreceptor agonist | |||
| 0.062 | 0.057 | 0.062 | Potassium channel (ATP-sensitive) blocker | |||
| 0.048 | 0.044 | 0.048 | Ribonucleotide reductase inhibitor | |||
| 0.037 | 0.032 | 0.037 | Toll-Like receptor 2 agonist | |||
| 0.015 | 0.011 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.009 CID_10683971 | CID_10683971 | |
| 0.042 | 0.038 | 0.042 | Adenosine deaminase inhibitor | |||
| 0.06 | 0.056 | 0.06 | Beta adrenoreceptor antagonist | |||
| 0.038 | 0.035 | 0.038 | Carbonic anhydrase IV inhibitor | |||
| 0.038 | 0.034 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.087 | 0.084 | 0.087 | Nitric-oxide synthase inhibitor | |||
| 0.031 | 0.029 | 0.031 | Angiotensin II receptor antagonist | |||
| 0.082 | 0.08 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.028 | 0.026 | 0.028 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.064 | 0.062 | 0.064 | Aminopeptidase I inhibitor | |||
| 0.077 | 0.076 | 0.077 | Estrogen-related receptor beta agonist | |||
| 0.037 | 0.036 | 0.037 | VCAM-1 antagonist | |||
| 0.019 | 0.018 | 0.019 | Factor XIII inhibitor | |||
| 0.043 | 0.042 | 0.043 | Thromboxane A2 antagonist | |||
| 0.037 | 0.036 | 0.037 | VCAM antagonist | |||
| 0.04 | 0.039 | 0.04 | Glycine transporter 2 inhibitor | |||
| 0.03 | 0.03 | 0.068 | Purinergic P2Y2 antagonist | 0.068 0.006 CID_10683971 | CID_10683971 | |
| 0.04 | 0.041 | 0.047 | Dihydrofolate reductase inhibitor | 0.047 0.023 CID_10683971 | CID_10683971 | |
| 0.102 | 0.116 | 0.157 | Antibacterial (Helicobacter pylori) | 0.157 0.041 CID_10683971 | CID_10683971 | |
| 0.054 | 0.071 | 0.149 | Neuraminidase (influenza) inhibitor | 0.149 0.008 CID_10683971 | CID_10683971 | |
| 0.043 | 0.067 | 0.077 | Heparanase inhibitor | 0.077 0.008 CID_10683971 | CID_10683971 | |
| 0.099 | 0.145 | 0.322 | Protein-tyrosine phosphatase inhibitor | 0.322 0.015 CID_10683971 | CID_10683971 | |
| 0.103 | 0.169 | 0.258 | Platelet adhesion inhibitor | 0.258 0.047 CID_10683971 | CID_10683971 | |
| 0.03 | 0.102 | 0.088 | Neuraminidase inhibitor | 0.088 0.02 CID_10683971 | CID_10683971 | |
| 0.009 | 0.088 | 0.027 | Glutamate (mGluR1a) agonist | 0.027 0.01 CID_10683971 | CID_10683971 | |
| 0.04 | 0.122 | 0.067 | Adenine nucleotide translocase inhibitor | 0.067 0.018 CID_10683971 | CID_10683971 | |
| 0.073 | 0.169 | 0.303 | Thrombolytic | 0.303 0.023 CID_10683971 | CID_10683971 | |
| 0.044 | 0.142 | 0.269 | CDC25A inhibitor | 0.269 0.004 CID_10683971 | CID_10683971 | |
| 0.02 | 0.122 | 0.044 | Leukocyte elastase inhibitor | 0.044 0.029 CID_10683971 | CID_10683971 | |
| 0.046 | 0.164 | 0.128 | Protein-tyrosine phosphatase 1B inhibitor | 0.128 0.057 CID_10683971 | CID_10683971 | |
| 0.034 | 0.161 | 0.069 | Phospholipase D inhibitor | 0.069 0.055 CID_10683971 | CID_10683971 | |
| 0.022 | 0.168 | 0.306 | Selectin antagonist | 0.306 0.005 CID_10683971 | CID_10683971 | |
| 0.054 | 0.221 | 0.092 | Nav1.4 sodium channel blocker | 0.092 0.089 CID_10683971 | CID_10683971 | |
| 0.095 | 0.292 | 0.25 | Beta lactamase inhibitor | 0.25 0.157 CID_10683971 | CID_10683971 | |
| 0.072 | 0.287 | 0.162 | Hemostatic | 0.162 0.055 CID_10683971 | CID_10683971 | |
| 0.003 | 0.325 | 0.04 | Estrone sulfatase inhibitor | 0.04 0.009 CID_10683971 | CID_10683971 | |
| 0.039 | 0.38 | 0.11 | Cell adhesion inhibitor | 0.11 0.074 CID_10683971 | CID_10683971 | |
| 0.004 | 0.387 | 0.05 | Cholecystokinin B antagonist | 0.05 0.01 CID_10683971 | CID_10683971 | |
| 0.011 | 0.443 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.024 CID_10683971 | CID_10683971 | |
| 0.004 | 0.498 | 0.062 | Cholecystokinin antagonist | 0.062 0.018 CID_10683971 | CID_10683971 | |
| 0.003 | 0.502 | 0.098 | Cholecystokinin A antagonist | 0.098 0.009 CID_10683971 | CID_10683971 | |
| 0.08 | 0.585 | 0.405 | Antiinflammatory | 0.405 0.137 CID_10683971 | CID_10683971 | |
| 0.011 | 0.588 | 0.113 | Cell adhesion molecule inhibitor | 0.113 0.027 CID_10683971 | CID_10683971 | |
| 0.008 | 0.69 | 0.41 | Cholecystokinin B agonist | 0.41 0.003 CID_10683971 | CID_10683971 | |
| 0.019 | 0.714 | 0.784 | Angiogenesis inhibitor | 0.784 0.005 CID_10683971 | CID_10683971 | |
| 0.004 | 0.701 | 0.144 | NMDA 2B receptor antagonist | 0.144 0.009 CID_10683971 | CID_10683971 | |
| 0.006 | 0.718 | 0.082 | Thrombin inhibitor | 0.082 0.039 CID_10683971 | CID_10683971 | |
| 0.005 | 0.726 | 0.07 | Elastase inhibitor | 0.07 0.022 CID_10683971 | CID_10683971 | |
| 0.012 | 0.779 | 0.171 | Factor IXa inhibitor | 0.171 0.004 CID_10683971 | CID_10683971 | |
| 0.006 | 0.802 | 0.597 | Anticoagulant | 0.597 0.006 CID_10683971 | CID_10683971 | |
| 0.002 | 0.904 | 0.182 | Cholecystokinin agonist | 0.182 0.003 CID_10683971 | CID_10683971 | |
| 0.002 | 0.929 | 0.152 | Cholecystokinin A agonist | 0.152 0.003 CID_10683971 | CID_10683971 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |